Trium Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,354
Closed -$5.47M 66
2024
Q3
$5.47M Sell
9,354
-2,177
-19% -$1.23M 1.56% 11
2024
Q2
$5.87M Sell
11,531
-4,283
-27% -$2.1M 0.74% 13
2024
Q1
$7.82M Buy
15,814
+2,434
+18% +$1.24M 2.93% 11
2023
Q4
$7.04K Buy
13,380
+672
+5% +$358K 0.57% 9
2023
Q3
$6.41K Buy
12,708
+120
+1% +$59.1K 0.12% 11
2023
Q2
$6.05K Buy
12,588
+2,312
+22% +$1.13M 1.29% 18
2023
Q1
$4.86M Buy
10,276
+289
+3% +$139K 1.68% 22
2022
Q4
$5.29M Buy
+9,987
New +$5.29M 1.95% 20

Other funds holding UNH

Trium Capital's UNH Position: Q4 2024 in Review

Trium Capital sold out of UnitedHealth (UNH) in Q4 2024, closing a stake of 9,354 shares — an estimated $5.47M sold.

Trium Capital first reported a position in UNH in Q4 2022 and held it in 8 quarters. The position peaked at $7.82M in Q1 2024. 3,674 funds tracked by Wall St. Rank hold UNH as of Q4 2024.

  • Trium Capital reported no remaining UnitedHealth position as of Q4 2024 after selling out during the quarter.
  • Trium Capital sold 9,354 UnitedHealth shares in Q4 2024, an estimated $5.47M.
  • Trium Capital first reported a position in UnitedHealth in Q4 2022 and held it in 8 quarters.
  • Trium Capital's UnitedHealth position peaked at $7.82M in Q1 2024.
  • 3,674 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2024.

Based on Trium Capital's 13F filing for Q4 2024, filed 15 Jan 2025.